Brain single-cell suspensions from 9-mo-old WT mice were stained with Ghost Dye violet 510 (1:1,000; Tonbo Biosciences) and anti–CD16/CD32 antibody (1:100; BD Biosciences) followed by anti-CD11b (1:100; BioLegend), anti-CD45 (1:100; BioLegend), anti-CD11c (1:50; BioLegend), anti-TMEM119 (1:200; Abcam), and anti-CCR2 (1:100; BioLegend). CD11b+ cells were gated from single/live cells followed by subsequent gating of CD11b+CD45low as microglia and CD11b+CD45high as macrophages. To distinguish microglia and macrophages, the CCR2 marker expressed by blood-derived macrophages but not by microglia was used (3 (link), 16 (link)). To further distinguish these two cell types, the microglia-specific marker Tmem119 (17 (link)) was also included. The CD11b+CD45high cells that express CCR2 but not Tmem119 were confirmed as macrophages, while the CD11b+CD45low cells that all express Tmem119 but do not express CCR2 were confirmed as microglia. FMO negative controls were included to confirm the specificity of CD11c staining in CD11b+CD45low microglial populations. Brain CD45 cells that mainly contain nonimmune cells (e.g., neurons, astrocytes, and oligodendrocytes) that do not express CD11c were also included as negative controls to further validate the specificity of this strategy.